P. Lassota

发表

Features of apoptotic cells measured by flow cytometry.

Z. Darżynkiewicz, S. Bruno, G. Del Bino, 1992, Cytometry.

Bengacarboline, a New β-Carboline from a Marine Ascidian Didemnum sp.

P. Lassota, C. Ireland, T. Foderaro, 1997 .

Non-Invasive Detection of a Small Number of Bioluminescent Cancer Cells In Vivo

Peter Lassota, B. Rice, P. Lassota, 2010, PloS one.

Selective Growth Inhibition of Tumor Cells by a Novel Histone Deacetylase Inhibitor, NVP-LAQ824

P. Atadja, D. Cohen, P. Lassota, 2004, Cancer Research.

N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824).

P. Atadja, P. Lassota, K. Bair, 2003, Journal of medicinal chemistry.

Altered Sensitivity of DNA in Situ to Denaturation in Apoptotic Cells a

Z. Darżynkiewicz, W. Gorczyca, P. Lassota, 1993, Annals of the New York Academy of Sciences.

REVIEW ARTICLE Features of Apoptotic Cells Measured by Flow Cytometry

S. Bruno, W. Gorczyca, P. Lassota, 1992 .

Evaluation of the mTOR inhibitor, everolimus, in combination with cytotoxic antitumor agents using human tumor models in vitro and in vivo

H. Lane, P. Lassota, T. O'reilly, 2011, Anti-cancer drugs.

Release of specific proteins from nuclei of HL-60 and MOLT-4 cells by antitumor drugs having affinity to nucleic acids.

M. Melamed, Z. Darżynkiewicz, P. Lassota, 1991, Biochemical pharmacology.

Motuporamines A−C, Cytotoxic Alkaloids Isolated from the Marine Sponge Xestospongia exigua (Kirkpatrick)

David E. Williams, R. Andersen, P. Lassota, 1998 .

Cytostatic and cytotoxic effects of fostriecin on human promyelocytic HL-60 and lymphocytic MOLT-4 leukemic cells.

Z. Darżynkiewicz, G. Del Bino, M. Hotz, 1992, Cancer research.

The S-phase cytotoxicity of camptothecin.

Z. Darżynkiewicz, G. Del Bino, P. Lassota, 1991, Experimental cell research.

07H239-A, a new cytotoxic eremophilane sesquiterpene from the marine-derived Xylariaceous fungus LL-07H239.

P. Lassota, G. Carter, L. McDonald, 2004, Journal of natural products.

Inhibition of tubulin polymerization by vitilevuamide, a bicyclic marine peptide, at a site distinct from colchicine, the vinca alkaloids, and dolastatin 10.

P. Lassota, C. Ireland, L. Barrows, 2002, Biochemical pharmacology.

Motuporamines A—C, Cytotoxic Alkaloids Isolated from the Marine Sponge Xestospongia exigua (Kirkpatrick).

David E. Williams, R. Andersen, P. Lassota, 1998 .

Bioluminescent imaging of Cdk2 inhibition in vivo

Peter Lassota, Nikolai Zhelev, Guo-Jun Zhang, 2004, Nature Medicine.

Disease models of cancer: apoptosis

P. Lassota, A. Kamb, 2004 .

Inhibitors of proteases prevent endonucleolysis accompanying apoptotic death of HL-60 leukemic cells and normal thymocytes.

Z. Darżynkiewicz, S. Bruno, G. Del Bino, 1992, Leukemia.

Apoptosis of rat thymocytes triggered by prednisolone, camptothecin, or teniposide is selective to G0 cells and is prevented by inhibitors of proteases.

Z. Darżynkiewicz, S. Bruno, P. Lassota, 1992, Oncology research.

A Spontaneous Acinar Cell Carcinoma Model for Monitoring Progression of Pancreatic Lesions and Response to Treatment Through Noninvasive Bioluminescence Imaging

P. Lassota, S. Lyons, Ning Zhang, 2009, Clinical Cancer Research.

Apoptotic death of lymphocytes upon treatment with 2-chloro-2'-deoxyadenosine (2-CdA).

Z. Darżynkiewicz, P. Lassota, Z. Kazimierczuk, 1994, Archivum immunologiae et therapiae experimentalis.

Papuamides A-D, HIV-inhibitory and cytotoxic depsipeptides from the sponges Theonella mirabilis and Theonella swinhoei, collected in Papua New Guinea

L. Pannell, K. Gustafson, M. Boyd, 1999 .

Genetically modified cancer models: the value of luciferase-tagged tumors and in vivo luciferase-based reporter assays in oncology drug discovery

P. Lassota, C. Kowal, E. Sorensen, 2003, Breast Cancer Research.

Veiutamine. A new alkaloid from the Fijian sponge Zyzzya fuliginosa

P. Lassota, C. Ireland, L. Barrows, 1997 .